phase readout
saveNCT07406854: A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation
ACTIVE_NOT_RECRUITINGupdated 48m ago
community read0 votes
Sponsor: Wuhan Neurophth Biotechnology Limited Company. Phase: PHASE3. Conditions: Leber Hereditary Optic Neuropathy (LHON)
view source ↗
comments(0)
5-min edit window · permanent after that